Past Speakers

 

27-29 October 2025
RAI Congress Center, Amsterdam

 

 

Nadiah Hanim Abdul Latif, President, Malaysian Rare Disorders Society

Nadiah Hanim Abdul Latif | President | Malaysian Rare Disorders Society » speaking at Orphan Drug Congress

Dennis Akkaya, Chief Commercial Officer, myTomorrows

Dennis Akkaya | Chief Commercial Officer | myTomorrows » speaking at Orphan Drug Congress

Gabriella Almberg, Head of Health System Policy & Public Affairs, UCB

Gabriella Almberg | Head of Health System Policy & Public Affairs | UCB » speaking at Orphan Drug Congress

Sofie Alverlind, Coordinator and Project Leader, Tandvards och Lakemedelsformansverket

Sofie Alverlind | Coordinator and Project Leader | Tandvards och Lakemedelsformansverket » speaking at Orphan Drug Congress

Inês Alves, President of the board, ANDO Portugal

Inês Alves | President of the board | ANDO Portugal » speaking at Orphan Drug Congress

José Ángel Aibar, President, Dravet Syndrome Foundation

José Ángel Aibar | President | Dravet Syndrome Foundation » speaking at Orphan Drug Congress

Derek Ansel, Vice President, Therapeutic Strategy Lead, Rare Disease, Worldwide Clinical Trials

Derek Ansel | Vice President, Therapeutic Strategy Lead, Rare Disease | Worldwide Clinical Trials » speaking at Orphan Drug Congress

Iolanda Arbiol, Cofunder and Director, Fundació Dr. Torrent-Farnell

Iolanda Arbiol | Cofunder and Director | Fundació Dr. Torrent-Farnell » speaking at Orphan Drug Congress

Emanuele Arca, Scientific Office lead - market access, OPEN Health

Emanuele Arca | Scientific Office lead - market access | OPEN Health » speaking at Orphan Drug Congress

Manuel Toledo Argany, Epileptologist, Vall d’Hebron Institute of Research

Manuel Toledo Argany | Epileptologist | Vall d’Hebron Institute of Research » speaking at Orphan Drug Congress

Alex Artyomenko, Global Patient Affairs Director of Rare Diseases, Ipsen

Alex Artyomenko | Global Patient Affairs Director of Rare Diseases | Ipsen » speaking at Orphan Drug Congress

Xavier Badia, Chief Executive Officer & Partner, OMAKASE CONSULTING

Xavier Badia | Chief Executive Officer & Partner | OMAKASE CONSULTING » speaking at Orphan Drug Congress

Rena Baek, Senior Director - Rare Diseases, Moderna, Inc.

Rena Baek | Senior Director - Rare Diseases | Moderna, Inc. » speaking at Orphan Drug Congress

Fabienne Bartoli, Inspector General, French National Authority for Health

Fabienne Bartoli | Inspector General | French National Authority for Health » speaking at Orphan Drug Congress

Soraya Bekkali, SVP, EUCAN & International Business of Alexion, AstraZeneca Rare Disease, Alexion Pharmaceuticals

Soraya Bekkali | SVP, EUCAN & International Business of Alexion, AstraZeneca Rare Disease | Alexion Pharmaceuticals » speaking at Orphan Drug Congress

Leticia Beleta, VP and General Manager Spain and Portugal, Alexion – AstraZeneca Rare Disease

Leticia Beleta | VP and General Manager Spain and Portugal | Alexion – AstraZeneca Rare Disease » speaking at Orphan Drug Congress

Debra Bellon, Strategic Engagement Manager, Rare Diseases International

Debra Bellon | Strategic Engagement Manager | Rare Diseases International » speaking at Orphan Drug Congress

Neil Bertelsen, Patient Engagement Specialist, Neil Bertelsen Consulting

Neil Bertelsen | Patient Engagement Specialist | Neil Bertelsen Consulting » speaking at Orphan Drug Congress

Mariam Bibi, Practice Lead, Remap Consulting

Mariam Bibi | Practice Lead | Remap Consulting » speaking at Orphan Drug Congress

Lindsay Birrell, Co-CEO, Realise Advocacy

Lindsay Birrell | Co-CEO | Realise Advocacy » speaking at Orphan Drug Congress

Corinne Blanchet, Executive Director, Program Delivery, Premier research

Corinne Blanchet | Executive Director, Program Delivery | Premier research » speaking at Orphan Drug Congress

Lara Bloom, President and CEO, The Ehlers-Danlos Society

Lara Bloom | President and CEO | The Ehlers-Danlos Society » speaking at Orphan Drug Congress

Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA, PTC Therapeutics

Thomas Bols | Head of Government Affairs and Patient Advocacy, EMEA | PTC Therapeutics » speaking at Orphan Drug Congress

Matt Bolz-Johnson, Mental Health Lead & Healthcare Advisor, EURORDIS

Matt Bolz-Johnson | Mental Health Lead & Healthcare Advisor | EURORDIS » speaking at Orphan Drug Congress

James Bonham, President, International Society for Neonatal Screening

James Bonham | President | International Society for Neonatal Screening » speaking at Orphan Drug Congress

Mathieu Boudes, Senior Advisor, FIPRA

Mathieu Boudes | Senior Advisor | FIPRA » speaking at Orphan Drug Congress

Nicholas Brooke, Founder and Executive Director, The Synergist

Nicholas Brooke | Founder and Executive Director | The Synergist » speaking at Orphan Drug Congress

Nicholas Brooke, Executive Director, Patient Focused Medicines Development

Nicholas Brooke | Executive Director | Patient Focused Medicines Development » speaking at Orphan Drug Congress

Virginie Bros-Facer, CEO, EURORDIS

Virginie Bros-Facer | CEO | EURORDIS » speaking at Orphan Drug Congress

Sarfati Bruno, CEO, Alfralo

Sarfati Bruno | CEO | Alfralo » speaking at Orphan Drug Congress

Thomas Butt, Executive Director, Health Economics & Outcomes Research, Biomarin

Thomas Butt | Executive Director, Health Economics & Outcomes Research | Biomarin » speaking at Orphan Drug Congress

Darren Callanan, Global Digital Lead, Partners4Access

Darren Callanan | Global Digital Lead | Partners4Access » speaking at Orphan Drug Congress

Natividad Calvente, Corporate Affairs Head Spain, Novartis

Natividad Calvente | Corporate Affairs Head Spain | Novartis » speaking at Orphan Drug Congress

Beatriz Carmona-Hidalgo, Postdoctoral Researcher, Junta de Andalucía

Beatriz Carmona-Hidalgo | Postdoctoral Researcher | Junta de Andalucía » speaking at Orphan Drug Congress

Jordi Carreras-Puigvert, CSO, Phenaros Pharmaceuticals AB

Jordi Carreras-Puigvert | CSO | Phenaros Pharmaceuticals AB » speaking at Orphan Drug Congress

Manuel Carrondo, Professor, iBET: Instituto de Biologia Experimental e Tecnológica

Manuel Carrondo | Professor | iBET: Instituto de Biologia Experimental e Tecnológica » speaking at Orphan Drug Congress

Manel Cascallo, General Director, Theriva Biologics

Manel Cascallo | General Director | Theriva Biologics » speaking at Orphan Drug Congress

Raquel Castro, Open Academy Director, Social Policy Director, EURORDIS

Raquel Castro | Open Academy Director, Social Policy Director | EURORDIS » speaking at Orphan Drug Congress

Maria Cavaller Bellaubi, Patient Engagement and Therapeutic Development Director, EURORDIS

Maria Cavaller Bellaubi | Patient Engagement and Therapeutic Development Director | EURORDIS » speaking at Orphan Drug Congress

Alison Cave, Chief Safety Officer, Medicines and Healthcare products Regulatory Agency

Alison Cave | Chief Safety Officer | Medicines and Healthcare products Regulatory Agency » speaking at Orphan Drug Congress

Helene Cederroth, Founder, President, Wilhelm Foundation

Helene Cederroth | Founder, President | Wilhelm Foundation » speaking at Orphan Drug Congress

Anne-Sophie Chalandon, Head of Global Public Affairs, Rare Diseases and CGT Policies, Sanofi

Anne-Sophie Chalandon | Head of Global Public Affairs, Rare Diseases and CGT Policies | Sanofi » speaking at Orphan Drug Congress

Fleur Chandler, Patient Advocate, Duchenne U.K.

Fleur Chandler | Patient Advocate | Duchenne U.K. » speaking at Orphan Drug Congress

Charlotte Chanson, Director Global Diagnostics, Orchard Therapeutics

Charlotte Chanson | Director Global Diagnostics | Orchard Therapeutics » speaking at Orphan Drug Congress

Hayley Chapman, Senior Program Director, The Synergist

Hayley Chapman | Senior Program Director | The Synergist » speaking at Orphan Drug Congress

Joana Claverol, Clinical Research Director, Barcelona Children's Hospital Sant Joan de Deu, Research foundation

Joana Claverol | Clinical Research Director | Barcelona Children's Hospital Sant Joan de Deu, Research foundation » speaking at Orphan Drug Congress

Kyle Clifton, Senior Director, Pricing & Market Access, Red Nucleus

Kyle Clifton | Senior Director, Pricing & Market Access | Red Nucleus » speaking at Orphan Drug Congress

Mónica Climente, Head of Pharmacy Service, Hospital Universitario Doctor Peset

Mónica Climente | Head of Pharmacy Service | Hospital Universitario Doctor Peset » speaking at Orphan Drug Congress

Angela Columbano, Head Business Development Partnership, Genethon

Angela Columbano | Head Business Development Partnership | Genethon » speaking at Orphan Drug Congress

Denis Costello, Director, CML Advocates Network

Denis Costello | Director | CML Advocates Network » speaking at Orphan Drug Congress

Catriona Crombie, Head of Rare Disease, LifeArc

Catriona Crombie | Head of Rare Disease | LifeArc » speaking at Orphan Drug Congress

Jordi Cruz, HPN Patient Association Representative and FEDER Patronage, FEDER

Jordi Cruz | HPN Patient Association Representative and FEDER Patronage | FEDER » speaking at Orphan Drug Congress

Antoine Daher, President, Casa Hunter

Antoine Daher | President | Casa Hunter » speaking at Orphan Drug Congress

Avril Daly, President, Eurordis - Rare Diseases Europe

Avril Daly | President | Eurordis - Rare Diseases Europe » speaking at Orphan Drug Congress

Gonzalo de Miquel, Vice President Clinical Development, Alexion – AstraZeneca Rare Disease

Gonzalo de Miquel | Vice President Clinical Development | Alexion – AstraZeneca Rare Disease » speaking at Orphan Drug Congress

Daniel De Vicente Corbeira, Board Member of FEDER, FEDER

Daniel De Vicente Corbeira | Board Member of FEDER | FEDER » speaking at Orphan Drug Congress

Hanka Dekker, Executive director, VKS

Hanka Dekker | Executive director | VKS » speaking at Orphan Drug Congress

Julien Delaye, Patient Engagement Manager – HTA, EURORDIS, EURORDIS

Julien Delaye | Patient Engagement Manager – HTA, EURORDIS | EURORDIS » speaking at Orphan Drug Congress

Maria Peña Diaz Jara, Head of the Social and Health Care and Resources Service, Castilla-la Mancha Regional Government

Maria Peña Diaz Jara | Head of the Social and Health Care and Resources Service | Castilla-la Mancha Regional Government » speaking at Orphan Drug Congress

Toon Digneffe, Head, Public Affairs & Public Policy, Europe & Canada, Takeda

Toon Digneffe | Head, Public Affairs & Public Policy, Europe & Canada | Takeda » speaking at Orphan Drug Congress

Danielle Dong, Global Rare Medical Affairs, Scientific Advocacy Lead, Sanofi

Danielle Dong | Global Rare Medical Affairs, Scientific Advocacy Lead | Sanofi » speaking at Orphan Drug Congress

João Duarte, Vice President, Regulatory Excellence, Ipsen

João Duarte | Vice President, Regulatory Excellence | Ipsen » speaking at Orphan Drug Congress

David Duro, VP Sales & BD, Lyfegen HealthTech AG

David Duro | VP Sales & BD | Lyfegen HealthTech AG » speaking at Orphan Drug Congress

Davelyn Eaves Hood, Senior Director of Medical & Patient Affairs, Rezolute, Inc.

Davelyn Eaves Hood | Senior Director of Medical & Patient Affairs | Rezolute, Inc. » speaking at Orphan Drug Congress

Islam ElTantawy, General Manager, IROS CRO

Islam ElTantawy | General Manager | IROS CRO » speaking at Orphan Drug Congress

Michael Epstein, VP and Head, Pricing and Commercial Strategy, Clinigen Group

Michael Epstein | VP and Head, Pricing and Commercial Strategy | Clinigen Group » speaking at Orphan Drug Congress

Wendy Erler, Vice President, Global Head Patient Experience & Insights, Alexion – AstraZeneca Rare Disease

Wendy Erler | Vice President, Global Head Patient Experience & Insights | Alexion – AstraZeneca Rare Disease » speaking at Orphan Drug Congress

Burcu Eryilmaz, Global Rare Diseases Franchise Head, Sanofi

Burcu Eryilmaz | Global Rare Diseases Franchise Head | Sanofi » speaking at Orphan Drug Congress

Elizabeth Estes, Executive Director, Open Source Imaging Consortium

Elizabeth Estes | Executive Director | Open Source Imaging Consortium » speaking at Orphan Drug Congress

Elise Evers, Senior Consultant, Initiate

Elise Evers | Senior Consultant | Initiate » speaking at Orphan Drug Congress

Adaeze Eze, Senior Research Consultant Strategic Market Access, OPEN Health

Adaeze Eze | Senior Research Consultant Strategic Market Access | OPEN Health » speaking at Orphan Drug Congress

Monica Ferrie, Chief Executive, Genetic Support Network of Victoria

Monica Ferrie | Chief Executive | Genetic Support Network of Victoria » speaking at Orphan Drug Congress

Peter Fish, Chief Executive Officer, Mendelian

Peter Fish | Chief Executive Officer | Mendelian » speaking at Orphan Drug Congress

Ella Fitzpatrick, Senior Public Involvement Adviser, National Institute for Health and Care Excellence

Ella Fitzpatrick | Senior Public Involvement Adviser | National Institute for Health and Care Excellence » speaking at Orphan Drug Congress

Manel Fontanet, Pharmacotherapeutic Harmonization Technician, Catalan Health Service

Manel Fontanet | Pharmacotherapeutic Harmonization Technician | Catalan Health Service » speaking at Orphan Drug Congress

Rita Francisco, Survey Project Manager, EURORDIS

Rita Francisco | Survey Project Manager | EURORDIS » speaking at Orphan Drug Congress

Roser Francisco, Head of the Clinical Accreditation Unit, Hospital Sant Joan de Déu

Roser Francisco | Head of the Clinical Accreditation Unit | Hospital Sant Joan de Déu » speaking at Orphan Drug Congress

Laura I. Furlong, Co-Founder & Scientific Director, MedBioinformatics

Laura I. Furlong | Co-Founder & Scientific Director | MedBioinformatics » speaking at Orphan Drug Congress

Félix Hugo Galarza Delgado, Executive President, Federacion Ecuatoriana de enfermedades raras o poco frecuentes FERPOF

Félix Hugo Galarza Delgado | Executive President | Federacion Ecuatoriana de enfermedades raras o poco frecuentes FERPOF » speaking at Orphan Drug Congress

Daniel-Anibal Garcia Diego, President, Federacion Espanola De Hemofilia

Daniel-Anibal Garcia Diego | President | Federacion Espanola De Hemofilia » speaking at Orphan Drug Congress

Almenia Garvey, Sr. Director Global Feasibility/Site Engagement, Allucent

Almenia Garvey | Sr. Director Global Feasibility/Site Engagement | Allucent » speaking at Orphan Drug Congress

Viviana Giannuzzi, Head of Research and Innovation Department, Gianni Benzi Pharmacological Research Foudation

Viviana Giannuzzi | Head of Research and Innovation Department | Gianni Benzi Pharmacological Research Foudation » speaking at Orphan Drug Congress

Alicia Gil, CEO&Owner, OMAKASE CONSULTING

Alicia Gil | CEO&Owner | OMAKASE CONSULTING » speaking at Orphan Drug Congress

Diego Fernando Gil Cardozo, President, Enfermedades Raras en el Caribe y América Latina (ERCAL)

Diego Fernando Gil Cardozo | President | Enfermedades Raras en el Caribe y América Latina (ERCAL) » speaking at Orphan Drug Congress

Anna Gilmore, Director of Patient Engagement, FSHD Society

Anna Gilmore | Director of Patient Engagement | FSHD Society » speaking at Orphan Drug Congress

Josie Godfrey, Director, JG Zebra Consulting

Josie Godfrey | Director | JG Zebra Consulting » speaking at Orphan Drug Congress

Adrian Goretzki, President, Healthcare Education Institute

Adrian Goretzki | President | Healthcare Education Institute » speaking at Orphan Drug Congress

Alicia Granados, Head, Global Rare Diseases Medical Scientific Advocacy, Sanofi

Alicia Granados | Head, Global Rare Diseases  Medical Scientific Advocacy | Sanofi » speaking at Orphan Drug Congress

Anabel Granja Dominguez, Researcher, Junta de Andalucía

Anabel Granja Dominguez | Researcher | Junta de Andalucía » speaking at Orphan Drug Congress

Lara Groves, Associate Director, Real-World Evidence, OPEN Health

Lara Groves | Associate Director, Real-World Evidence | OPEN Health » speaking at Orphan Drug Congress

Marcus Guardian, CEO, International Horizon Scanning Initative

Marcus Guardian | CEO | International Horizon Scanning Initative » speaking at Orphan Drug Congress

Encarna Guillén-Navarro, Directora Asistencial, UNICAS

Encarna Guillén-Navarro | Directora Asistencial | UNICAS » speaking at Orphan Drug Congress

Pina Haberl, Senior Director, Partners4Access

Pina Haberl | Senior Director | Partners4Access » speaking at Orphan Drug Congress

Victoria Hedley, Rare Disease Policy Manger, Newcastle University

Victoria Hedley | Rare Disease Policy Manger | Newcastle University » speaking at Orphan Drug Congress

Christian Hendriksz, Medical and Strategic Advisor, A Rare Cause

Christian Hendriksz | Medical and Strategic Advisor | A Rare Cause » speaking at Orphan Drug Congress

Cesar Hernandez, General Director of Pharmacy, Spanish Ministry of Health

Cesar Hernandez | General  Director of Pharmacy | Spanish Ministry of Health » speaking at Orphan Drug Congress

Johannes Heuckeroth, Public Affairs & Patient Advocacy Lead Germany, UCB

Johannes Heuckeroth | Public Affairs & Patient Advocacy Lead Germany | UCB » speaking at Orphan Drug Congress

Alexandra Heumber Perry, Chief Executive Officer, Rare Diseases International

Alexandra Heumber Perry | Chief Executive Officer | Rare Diseases International » speaking at Orphan Drug Congress

David Hipkiss, Executive Chair, AlveoGene

David Hipkiss | Executive Chair | AlveoGene » speaking at Orphan Drug Congress

Kate Holliday, Chief Executive, CCDR/Pathways Telehealth Nurse Service

Kate Holliday | Chief Executive | CCDR/Pathways Telehealth Nurse Service » speaking at Orphan Drug Congress

Sicily Ifpa, Scientific Officer, International Federation Of Psoriasis Associations

Sicily Ifpa | Scientific Officer | International Federation Of Psoriasis Associations » speaking at Orphan Drug Congress

Monica Ines, HEOR Team Leader, Hemophilia, Pfizer

Monica Ines | HEOR Team Leader, Hemophilia | Pfizer » speaking at Orphan Drug Congress

Giorgio Iotti, Head Of Pipeline and Portfolio Leadership, Global Rare Diseases R&D, Chiesi Farmaceutici SpA

Giorgio Iotti | Head Of Pipeline and Portfolio Leadership, Global Rare Diseases R&D | Chiesi Farmaceutici SpA » speaking at Orphan Drug Congress

Julian Isla, Director, Foundation 29

Julian Isla | Director | Foundation 29 » speaking at Orphan Drug Congress

Mohit Jain, VP Global Head, Value, Access & Strategic Pricing, Biomarin

Mohit Jain | VP Global Head, Value, Access & Strategic Pricing | Biomarin » speaking at Orphan Drug Congress

Ritu Jain, President, DEBRA Singapore

Ritu Jain | President | DEBRA Singapore » speaking at Orphan Drug Congress

Emma James, VP Clinical/Medical Affairs, Encoded Therapeutics

Emma James | VP Clinical/Medical Affairs | Encoded Therapeutics » speaking at Orphan Drug Congress

Annika Jodicke, Senior Researcher in Pharmacoepidemiology, University of Oxford NDORMS

Annika Jodicke | Senior Researcher in Pharmacoepidemiology | University of Oxford NDORMS » speaking at Orphan Drug Congress

Olivia Johns, Associate Consultant, Partners4Access

Olivia Johns | Associate Consultant | Partners4Access » speaking at Orphan Drug Congress

Gabriel Johnson, Operations Manager, Instituto Unidos pela Vida

Gabriel Johnson | Operations Manager | Instituto Unidos pela Vida » speaking at Orphan Drug Congress

Kirsten Johnson, Chair of Council RDI & Board Member, EURORDIS, EURORDIS

Kirsten Johnson | Chair of Council RDI & Board Member, EURORDIS | EURORDIS » speaking at Orphan Drug Congress

Anneliene Jonker, Rare Disease Therapy Researcher, University of Twente

Anneliene Jonker | Rare Disease Therapy Researcher | University of Twente » speaking at Orphan Drug Congress

Ron Jortner, Founder & CEO, Aspire Biosciences

Ron Jortner | Founder & CEO | Aspire Biosciences » speaking at Orphan Drug Congress

Daria Julkowska, Scientific Coordination, European RD Research Alliance, IRDiRC

Daria Julkowska | Scientific Coordination, European RD Research Alliance | IRDiRC » speaking at Orphan Drug Congress

Ken Kengatharan, Managing General Partner, Atheneos Ventures

Ken Kengatharan | Managing General Partner | Atheneos Ventures » speaking at Orphan Drug Congress

Maciek Klein, Global Chief Business Officer, Saventic Health GmbH

Maciek Klein | Global Chief Business Officer | Saventic Health GmbH » speaking at Orphan Drug Congress

Tomasz Kluszczynski, Strategy Consultant & Founder, ACESO Healthcare

Tomasz Kluszczynski | Strategy Consultant & Founder | ACESO Healthcare » speaking at Orphan Drug Congress

Hasan Kobat, Global Business Development Lead, Real World Data, Clinigen Group

Hasan Kobat | Global Business Development Lead, Real World Data | Clinigen Group » speaking at Orphan Drug Congress

David Kolar, Executive Director, AIFP

David Kolar | Executive Director | AIFP » speaking at Orphan Drug Congress

Lauren Kopsick, Founder and Executive Director, The Healthcare Navigation Project

Lauren Kopsick | Founder and Executive Director | The Healthcare Navigation Project » speaking at Orphan Drug Congress

Jonathan Kornstein, Vice President, Rare Disease and Pediatrics, CAIDYA

Jonathan Kornstein | Vice President, Rare Disease and Pediatrics | CAIDYA » speaking at Orphan Drug Congress

Parvathy Krishnan, Executive Director, Krishnan Family Foundation

Parvathy Krishnan | Executive Director | Krishnan Family Foundation » speaking at Orphan Drug Congress

Sarka Kubinova, Medical evaluator, MoCA coordinator, Czech Republic State Institute for Drug Control

Sarka Kubinova | Medical evaluator, MoCA coordinator | Czech Republic State Institute for Drug Control » speaking at Orphan Drug Congress

Evert Kueppers, CEO, BOOST Pharma ApS

Evert Kueppers | CEO | BOOST Pharma ApS » speaking at Orphan Drug Congress

Oleg Kvlividze, CEO, Georgian Foundation for Genetic and Rare Diseases

Oleg Kvlividze | CEO | Georgian Foundation for Genetic and Rare Diseases » speaking at Orphan Drug Congress

Stelios Kympouropoulos, MEP, European Parliament

Stelios Kympouropoulos | MEP | European Parliament » speaking at Orphan Drug Congress

Yann Le Cam, Founder and past-CEO, EURORDIS

Yann Le Cam | Founder and past-CEO | EURORDIS » speaking at Orphan Drug Congress

Nick Leach, Founder, Red Thread Market Access Ltd

Nick Leach | Founder | Red Thread Market Access Ltd » speaking at Orphan Drug Congress

Tim Leest, Clinical Assessor Efficacy and Safety & Chair of COMP EMA, F.A.M.H.P

Tim Leest | Clinical Assessor Efficacy and Safety & Chair of COMP EMA | F.A.M.H.P » speaking at Orphan Drug Congress

James Levine, President, Fondation Ipsen

James Levine | President | Fondation Ipsen » speaking at Orphan Drug Congress

Kieron Lewis, Director of Strategic Consulting, Clinigen Group

Kieron Lewis | Director of Strategic Consulting | Clinigen Group » speaking at Orphan Drug Congress

Flaminia Macchia, Head Global Rare Disease Policy, Alexion – AstraZeneca Rare Disease

Flaminia Macchia | Head Global Rare Disease Policy | Alexion – AstraZeneca Rare Disease » speaking at Orphan Drug Congress

Victor Maertens, Government Affairs Manager, European Confederation of Pharmaceutical Entrepreneurs

Victor Maertens | Government Affairs Manager | European Confederation of Pharmaceutical Entrepreneurs » speaking at Orphan Drug Congress

Nitin Mahadev, Vice President, Global Franchise Lead, Rare Disease, Pfizer

Nitin Mahadev | Vice President, Global Franchise Lead, Rare Disease | Pfizer » speaking at Orphan Drug Congress

Fenna Mahler, Head of operations and expert services, conect4children

Fenna Mahler | Head of operations and expert services | conect4children » speaking at Orphan Drug Congress

Hadley Mahon, Head of Commercial and Product, Mendelian

Hadley Mahon | Head of Commercial and Product | Mendelian » speaking at Orphan Drug Congress

Owen Male, Senior Associate, CRA, Charles River Associates

Owen Male | Senior Associate | CRA, Charles River Associates » speaking at Orphan Drug Congress

Farzana Malik, Managing Partner, Independent Market Access Expert

Farzana Malik | Managing Partner | Independent Market Access Expert » speaking at Orphan Drug Congress

Karen Malone, CEO, GeneScape

Karen Malone | CEO | GeneScape » speaking at Orphan Drug Congress

Robin Marcus, Head of Global DCT Market Development, Marken

Robin Marcus | Head of Global DCT Market Development | Marken » speaking at Orphan Drug Congress

Milan Marinkov, Executive Medical Director, TA Medical Lead, Allucent

Milan Marinkov | Executive Medical Director, TA Medical Lead | Allucent » speaking at Orphan Drug Congress

Lisa Marsden, SVP Global Value & Access, Ipsen

Lisa Marsden | SVP Global Value & Access | Ipsen » speaking at Orphan Drug Congress

Silvia Martin Lluesma, Head of Advanced Therapies Program, VHIO

Silvia Martin Lluesma | Head of Advanced Therapies Program | VHIO » speaking at Orphan Drug Congress

Drew Matheson, Executive Director. Franchise Area Lead Respiratory Medicine and Infectious Disease, Worldwide Clinical Trials

Drew Matheson | Executive Director. Franchise Area Lead Respiratory Medicine and Infectious Disease | Worldwide Clinical Trials » speaking at Orphan Drug Congress

Lucy Mckay, Chief Executive Officer, Medics4RareDiseases

Lucy Mckay | Chief Executive Officer | Medics4RareDiseases » speaking at Orphan Drug Congress

Linda McNamara, Senior Director, Market Access, WEP Clinical

Linda McNamara | Senior Director, Market Access | WEP Clinical » speaking at Orphan Drug Congress

Nick Meade, Director of Policy, Genetic Alliance U.K.

Nick Meade | Director of Policy | Genetic Alliance U.K. » speaking at Orphan Drug Congress

Stuart Mealing, Associate Director (HEOR), York Health Economics Consortium

Stuart Mealing | Associate Director (HEOR) | York Health Economics Consortium » speaking at Orphan Drug Congress

Annamaria Merico, Head of Business Development, Fondazione Telethon

Annamaria Merico | Head of Business Development | Fondazione Telethon » speaking at Orphan Drug Congress

Jorge Mestre-Ferrandiz, Associate Professor, Universidad Carlos III de Madrid

Jorge Mestre-Ferrandiz | Associate Professor | Universidad Carlos III de Madrid » speaking at Orphan Drug Congress

Estelle Michael, Policy and public affairs lead, UCB

Estelle Michael | Policy and public affairs lead | UCB » speaking at Orphan Drug Congress

Susanne Michel, Vice President Market Access, Clinigen

Susanne Michel | Vice President Market Access | Clinigen » speaking at Orphan Drug Congress

Ann-Lise Mikolajczak, Manager Global Health and Access, IFPMA

Ann-Lise Mikolajczak | Manager Global Health and Access | IFPMA » speaking at Orphan Drug Congress

Federica Miotto, head of medical affairs, Fondazione Telethon

Federica Miotto | head of medical affairs | Fondazione Telethon » speaking at Orphan Drug Congress

Bojana Mirosavljevic, Director, Patient Advocacy Strategy, Center for Rare Diseases, ICON PLC

Bojana Mirosavljevic | Director, Patient Advocacy Strategy, Center for Rare Diseases | ICON PLC » speaking at Orphan Drug Congress

Geert Molenberghs, Professor, Hasselt University

Geert Molenberghs | Professor | Hasselt University » speaking at Orphan Drug Congress

Gillian Molloy, VP, Market Access, AscellaHealth

Gillian Molloy | VP, Market Access | AscellaHealth » speaking at Orphan Drug Congress

Maria Molnar, Professor of Neurology, Psychiatry, Clinical Genetics and Clinico-pharmacology, Semmelweis University

Maria Molnar | Professor of Neurology, Psychiatry, Clinical Genetics and Clinico-pharmacology | Semmelweis University » speaking at Orphan Drug Congress

Cristina Montané, Patient Advocate, Acaf

Cristina Montané | Patient Advocate | Acaf » speaking at Orphan Drug Congress

Marisol Montolio, Director of Research, Duchenne Parent Project Spain

Marisol Montolio | Director of Research | Duchenne Parent Project Spain » speaking at Orphan Drug Congress

Meghan Morgan-Smith, Director, Therapeutic Area, ICON PLC

Meghan Morgan-Smith | Director, Therapeutic Area | ICON PLC » speaking at Orphan Drug Congress

Paolo Morgese, Vice President, Public Affairs, Europe, Alliance for Regenerative Medicine

Paolo Morgese | Vice President, Public Affairs, Europe | Alliance for Regenerative Medicine » speaking at Orphan Drug Congress

Juliet Moritz, Senior VP Strategic Solutions and Patient Centricity, Ergomed

Juliet Moritz | Senior VP Strategic Solutions and Patient Centricity | Ergomed » speaking at Orphan Drug Congress

David Morrow, Senior Scientific Program Manager, EATRIS

David Morrow | Senior Scientific Program Manager | EATRIS » speaking at Orphan Drug Congress

Andrew Mumford, Chief Executive Officer, Initiate Consultancy

Andrew Mumford | Chief Executive Officer | Initiate Consultancy » speaking at Orphan Drug Congress

Elaine Murphy, Senior Regulatory Affairs Strategist, Clinigen Group

Elaine Murphy | Senior Regulatory Affairs Strategist | Clinigen Group » speaking at Orphan Drug Congress

Rima Nabbout, MD/PhD, Hopital Necker- Enfants Malades

Rima Nabbout | MD/PhD | Hopital Necker- Enfants Malades » speaking at Orphan Drug Congress

Begonya Nafria Escalera, Patient Engagement in Research Coordinator, SJD Children's Hospital

Begonya Nafria Escalera | Patient Engagement in Research Coordinator | SJD Children's Hospital » speaking at Orphan Drug Congress

Petra Nathan, CRMA, Novartis Pharma GmbH

Petra Nathan | CRMA | Novartis Pharma GmbH » speaking at Orphan Drug Congress

Alexander Natz, Secretary General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs

Alexander Natz | Secretary General | EUCOPE - European Confederation of Pharmaceutical Entrepreneurs » speaking at Orphan Drug Congress

Frauke Naumann-Winter, Head of Unit, BfArM

Frauke Naumann-Winter | Head of Unit | BfArM » speaking at Orphan Drug Congress

Manzi Ndamukunze, Chairman, CENTRE-ALLIANCE FOR RARE DISEASES IN RWANDA

Manzi Ndamukunze | Chairman | CENTRE-ALLIANCE FOR RARE DISEASES IN RWANDA » speaking at Orphan Drug Congress

Jonathan Neal, Head Pipeline & Portfolio Europe & Canada, Takeda

Jonathan Neal | Head Pipeline & Portfolio Europe & Canada | Takeda » speaking at Orphan Drug Congress

Emilie Neez, Director, Dolon

Emilie Neez | Director | Dolon » speaking at Orphan Drug Congress

Stefan Neudoerfer, Executive Director, Head Market Access & Pricing Europe, C.S.L. Behring Gmbh

Stefan Neudoerfer | Executive Director, Head Market Access & Pricing Europe | C.S.L. Behring Gmbh » speaking at Orphan Drug Congress

Elena Nicod, Director, Dolon

Elena Nicod | Director | Dolon » speaking at Orphan Drug Congress

Trudy Nyakambangwe, Director, Child and Youth Care

Trudy Nyakambangwe | Director | Child and Youth Care » speaking at Orphan Drug Congress

Daniel O'Connor, Director, Regulatory Policy & Early Access, ABPI

Daniel O'Connor | Director, Regulatory Policy & Early Access | ABPI » speaking at Orphan Drug Congress

Colin O'Donnell, Head of EUCAN & International Government Affairs, Alexion – AstraZeneca Rare Disease

Colin O'Donnell | Head of EUCAN & International Government Affairs | Alexion – AstraZeneca Rare Disease » speaking at Orphan Drug Congress

Andrew Olaye, Head of EMEA Market Access, Orchard Therapeutics Ltd

Andrew Olaye | Head of EMEA Market Access | Orchard Therapeutics Ltd » speaking at Orphan Drug Congress

Sue O'Leary, Executive Vice President, Evidence and Access, Prime Global

Sue O'Leary | Executive Vice President, Evidence and Access | Prime Global » speaking at Orphan Drug Congress

Juan Dario Ortigoza Escobar, Paediatric Neurologist Consultant, Hospital Sant Joan de Déu

Juan Dario Ortigoza Escobar | Paediatric Neurologist Consultant | Hospital Sant Joan de Déu » speaking at Orphan Drug Congress

Amrita Ostawal, Senior Director, Market Access, OPEN Health

Amrita Ostawal | Senior Director, Market Access | OPEN Health » speaking at Orphan Drug Congress

Rachel Paiva Petean Abu Taleb, Medical Monitor, Veristat

Rachel Paiva Petean Abu Taleb | Medical Monitor | Veristat » speaking at Orphan Drug Congress

Gloria M. Palomo Carrasco, Head of Service ATMPs and Vaccines, NonClinical Division, Medicines for Human Use Department, AEMPS

Gloria M. Palomo Carrasco | Head of Service ATMPs and Vaccines, NonClinical Division, Medicines for Human Use Department | AEMPS » speaking at Orphan Drug Congress

Francis Pang, SVP Global Market Access and International Geographic Expansion, Orchard Therapeutics

Francis Pang | SVP Global Market Access and International Geographic Expansion | Orchard Therapeutics » speaking at Orphan Drug Congress

Samantha Parker, Patient Advocacy and Communication Lead Rare Diseases, Italfarmaco

Samantha Parker | Patient Advocacy and Communication Lead Rare Diseases | Italfarmaco » speaking at Orphan Drug Congress

Bhavesh Patel, Principal, Life Sciences Strategy Consulting, CRA, Charles River Associates

Bhavesh Patel | Principal, Life Sciences Strategy Consulting | CRA, Charles River Associates » speaking at Orphan Drug Congress

David Pearce, Chair, Sanford Health

David Pearce | Chair | Sanford Health » speaking at Orphan Drug Congress

Lorna Pender, Global Patient Engagement Lead, Clinigen Group

Lorna Pender | Global Patient Engagement Lead | Clinigen Group » speaking at Orphan Drug Congress

Cristian Perez, Director of International Patient Affairs, Blueprint Medicines

Cristian Perez | Director of International Patient Affairs | Blueprint Medicines » speaking at Orphan Drug Congress

Lesley Perkin, Patient Engagement & Policy Lead, UK & Ireland, UCB

Lesley Perkin | Patient Engagement & Policy Lead, UK & Ireland | UCB » speaking at Orphan Drug Congress

Louise Perrault, President & Chief Executive Officer, International Market Access Consulting, GmbH

Louise Perrault | President & Chief Executive Officer | International Market Access Consulting, GmbH » speaking at Orphan Drug Congress

Enrico Piccinini, Senior Vice President, EU & International, Rare Diseases, Chiesi Group

Enrico Piccinini | Senior Vice President, EU & International, Rare Diseases | Chiesi Group » speaking at Orphan Drug Congress

Vinciane Pirard, Medical - SAI, Sanofi

Vinciane Pirard | Medical - SAI | Sanofi » speaking at Orphan Drug Congress

Michele Pistollato, Principal, Charles River Associates

Michele Pistollato | Principal | Charles River Associates » speaking at Orphan Drug Congress

Anna Planagumà, Licensing Associate Director, Almirall

Anna Planagumà | Licensing Associate Director | Almirall » speaking at Orphan Drug Congress

Charlotte Poon, Senior Associate, CRA, Charles River Associates

Charlotte Poon | Senior Associate | CRA, Charles River Associates » speaking at Orphan Drug Congress

Stefano Portolano, CEO, Azafaros

Stefano Portolano | CEO | Azafaros » speaking at Orphan Drug Congress

Xenia Proton de la Chapelle, CEO, AtmosR

Xenia Proton de la Chapelle | CEO | AtmosR » speaking at Orphan Drug Congress

Ruth Pulikottil Jacob, EMEA HEOR Lead, Cepheid

Ruth Pulikottil Jacob | EMEA HEOR Lead | Cepheid » speaking at Orphan Drug Congress

Jennifer Quinn, Head of Global Value and Access, Debiopharm international

Jennifer Quinn | Head of Global Value and Access | Debiopharm international » speaking at Orphan Drug Congress

Vinciane Quoidbach, Manager, Public Health And Policy, Research Project, European Brain Council

Vinciane Quoidbach | Manager, Public Health And Policy, Research Project | European Brain Council » speaking at Orphan Drug Congress

Lindsay Randall, Founder and Chief Executive Officer, Arthur's Quest/ SLC6A1 Connect UK

Lindsay Randall | Founder and Chief Executive Officer | Arthur's Quest/ SLC6A1 Connect UK » speaking at Orphan Drug Congress

Ana Rath, Director, Orphanet / INSERM US14

Ana Rath | Director | Orphanet / INSERM US14 » speaking at Orphan Drug Congress

Ian Rentsch, GM Pharma, Centogene

Ian Rentsch | GM Pharma | Centogene » speaking at Orphan Drug Congress

David Rintell, Head Of Patient Advocacy, BridgeBio Pharma

David Rintell | Head Of Patient Advocacy | BridgeBio Pharma » speaking at Orphan Drug Congress

Shawn Ritchie, Chief Executive Officer, Med-Life Discoveries

Shawn Ritchie | Chief Executive Officer | Med-Life Discoveries » speaking at Orphan Drug Congress

Georgia Roberts, Senior Consultant, Initiate

Georgia Roberts | Senior Consultant | Initiate » speaking at Orphan Drug Congress

Lauren Roberts, Head of Development, Rareminds

Lauren Roberts | Head of Development | Rareminds » speaking at Orphan Drug Congress

Toni Roberts, Patient & NPO Co Founder, DEBRA South Africa

Toni Roberts | Patient & NPO Co Founder | DEBRA South Africa » speaking at Orphan Drug Congress

Jessica Roberts, Director, Pharmacometrics, Allucent

Jessica Roberts | Director, Pharmacometrics | Allucent » speaking at Orphan Drug Congress

Laura Rodriguez Gallego, Partner, Invivo Partners

Laura Rodriguez Gallego | Partner | Invivo Partners » speaking at Orphan Drug Congress

Stefano Romanelli, Senior Government Affairs Manager, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Stefano Romanelli | Senior Government Affairs Manager | European Confederation of Pharmaceutical Entrepreneurs (Belgium) » speaking at Orphan Drug Congress

Clara Romero, Account Director, FIPRA/ Together for rare diseases

Clara Romero | Account Director | FIPRA/ Together for rare diseases » speaking at Orphan Drug Congress

Kacper Rucinski, Strategy Board, SMA Foundation Poland Steering Committee, SMA Europe

Kacper Rucinski | Strategy Board, SMA Foundation Poland Steering Committee | SMA Europe » speaking at Orphan Drug Congress

Kacper Rucinski, Executive Committee Member, SMA Europe

Kacper Rucinski | Executive Committee Member | SMA Europe » speaking at Orphan Drug Congress

Christopher Rudolf, Founder and Chief Executive Officer, Volv Global

Christopher Rudolf | Founder and Chief Executive Officer | Volv Global » speaking at Orphan Drug Congress

Antoni Salgado Soler, Patient Access Lead, Mereo

Antoni Salgado Soler | Patient Access Lead | Mereo » speaking at Orphan Drug Congress

Adrien Samson, Healthcare Policy Senior Manager, EuropaBio

Adrien Samson | Healthcare Policy Senior Manager | EuropaBio » speaking at Orphan Drug Congress

Arantxa Sancho, Medical Director, Farmaindustria

Arantxa Sancho | Medical Director | Farmaindustria » speaking at Orphan Drug Congress

Ina Sarel, Director of QA, RA, NurExone Biologic

Ina Sarel | Director of QA, RA | NurExone Biologic » speaking at Orphan Drug Congress

Robin Sarfati, CTO, Tekkare

Robin Sarfati | CTO | Tekkare » speaking at Orphan Drug Congress

Matteo Scarabelli, Market Access, Associated Director, EFPIA - European Federation of Pharmaceutical Industries and Associations

Matteo Scarabelli | Market Access, Associated Director | EFPIA - European Federation of Pharmaceutical Industries and Associations » speaking at Orphan Drug Congress

Maurizio Scarpa, Director, Coordinating Center For Rare Diseases, MetabERN

Maurizio Scarpa | Director, Coordinating Center For Rare Diseases | MetabERN » speaking at Orphan Drug Congress

Sophie Schmitz, Managing Partner, Partners4Access

Sophie Schmitz | Managing Partner | Partners4Access » speaking at Orphan Drug Congress

Jennifer Schranz, SVP, Global Head Rare Diseases, Ipsen

Jennifer Schranz | SVP, Global Head Rare Diseases | Ipsen » speaking at Orphan Drug Congress

Ulrike Schwerdfeger, Executive Officer, WHO

Ulrike Schwerdfeger | Executive Officer | WHO » speaking at Orphan Drug Congress

Ross Selby, Value, Access & External Affairs Director, Italfarmaco

Ross Selby | Value, Access & External Affairs Director | Italfarmaco » speaking at Orphan Drug Congress

Mukesh Sharma, Head of Early Pipeline and Business Development, Alexion – AstraZeneca Rare Disease

Mukesh Sharma | Head of Early Pipeline and Business Development | Alexion – AstraZeneca Rare Disease » speaking at Orphan Drug Congress

Simon Shohet, VP International Market Access and HEOR, Amicus Therapeutics

Simon Shohet | VP International Market Access and HEOR | Amicus Therapeutics » speaking at Orphan Drug Congress

Jenny Shum, VP Corporate Affairs Alexion AZ EUCAN, AstraZeneca

Jenny Shum | VP Corporate Affairs Alexion AZ EUCAN | AstraZeneca » speaking at Orphan Drug Congress

Natascha Sippel-Schönborn, Managing direktor, MFSH e.V.

Natascha Sippel-Schönborn | Managing direktor | MFSH e.V. » speaking at Orphan Drug Congress

Nick Sireau, Chair and Chief Executive Officer, AKU Society

Nick Sireau | Chair and Chief Executive Officer | AKU Society » speaking at Orphan Drug Congress

Claire Skentelbery, Director General, EuropaBio

Claire Skentelbery | Director General | EuropaBio » speaking at Orphan Drug Congress

Rachel Smith, Global Head, Rare Disease, Parexel

Rachel Smith | Global Head, Rare Disease | Parexel » speaking at Orphan Drug Congress

Tara Smith, Exec VP, Innovative Therapies, Med-Life Discoveries

Tara Smith | Exec VP, Innovative Therapies | Med-Life Discoveries » speaking at Orphan Drug Congress

Oskar Smrzka, CEO/CSO, Ablevia biotech Gmbh

Oskar Smrzka | CEO/CSO | Ablevia biotech Gmbh » speaking at Orphan Drug Congress

Oriol Solà-Morales, Chief Executive Officer, HiTT

Oriol Solà-Morales | Chief Executive Officer | HiTT » speaking at Orphan Drug Congress

Leire Solis, Health Policy and Advocacy Manager, IPOPI

Leire Solis | Health Policy and Advocacy Manager | IPOPI » speaking at Orphan Drug Congress

Wodc 2024 Speaker, Speaker Guest, Terrapinn

Wodc 2024 Speaker | Speaker Guest | Terrapinn » speaking at Orphan Drug Congress

Bob Stevens, Group CEO, MPS Society

Bob Stevens | Group CEO | MPS Society » speaking at Orphan Drug Congress

Alexandra Tataru, IRDiRC

Alexandra Tataru |  | IRDiRC » speaking at Orphan Drug Congress

Elizabeth Taylor, Senior Regulatory Affairs Manager, Clinigen Group

Elizabeth Taylor | Senior Regulatory Affairs Manager | Clinigen Group » speaking at Orphan Drug Congress

Ana Tediosi, Head of Expanded Access Program Strategy, WEP Clinical

Ana Tediosi | Head of Expanded Access Program Strategy | WEP Clinical » speaking at Orphan Drug Congress

Luca Trentin, Patient Engagement Senior Consultant, Alira Health

Luca Trentin | Patient Engagement Senior Consultant | Alira Health » speaking at Orphan Drug Congress

Sheela Upadhyaya, Life Science Advisor in Rare Diseases & Special Advisor, Openflex Ltd

Sheela Upadhyaya | Life Science Advisor in Rare Diseases & Special Advisor | Openflex Ltd » speaking at Orphan Drug Congress

Anton Ussi, Operations Director, EATRIS ERIC

Anton Ussi | Operations Director | EATRIS ERIC » speaking at Orphan Drug Congress

Sonia Valero, Head Of Clinical Operations - Patient Advocacy Leader, Vivet Therapeutics

Sonia Valero | Head Of Clinical Operations - Patient Advocacy Leader | Vivet Therapeutics » speaking at Orphan Drug Congress

Johan van Eldere, secretary-general, European University Hospital Alliance

Johan van Eldere | secretary-general | European University Hospital Alliance » speaking at Orphan Drug Congress

Leon van Wouwe, Clinical Innovation Director, Volv Global

Leon van Wouwe | Clinical Innovation Director | Volv Global » speaking at Orphan Drug Congress

Lavni Varyani, Founding Partner, Pharma Business Partners

Lavni Varyani | Founding Partner | Pharma Business Partners » speaking at Orphan Drug Congress

Nicole Verdun, Super Office Director, Food and Drug Administration

Nicole Verdun | Super Office Director | Food and Drug Administration » speaking at Orphan Drug Congress

Daniel Vidal Moreira, Co-Founder, Cellbyte GmbH

Daniel Vidal Moreira | Co-Founder | Cellbyte GmbH » speaking at Orphan Drug Congress

Mary Wang, Global Programme Director, Rare Diseases International

Mary Wang | Global Programme Director | Rare Diseases International » speaking at Orphan Drug Congress

Allison Watson, CEO, Ring20 Research and Support UK CIO

Allison Watson | CEO | Ring20 Research and Support UK CIO » speaking at Orphan Drug Congress

Emily White, PhD Researcher & Project Manager, Endo-ERN

Emily White | PhD Researcher & Project Manager | Endo-ERN » speaking at Orphan Drug Congress

Andrea Wilkinson, Global Head of Epilepsy Patient Engagement, UCB

Andrea Wilkinson | Global Head of Epilepsy Patient Engagement | UCB » speaking at Orphan Drug Congress

Genevieve Wills, Associate Director, Biostatistical Consulting, Allucent

Genevieve Wills | Associate Director, Biostatistical Consulting | Allucent » speaking at Orphan Drug Congress

Nicky Wisener, Vice-President of Business Development, Clinigen Group

Nicky Wisener | Vice-President of Business Development | Clinigen Group » speaking at Orphan Drug Congress

Durhane Wong-Rieger, President, Chief Executive Officer, Canadian Organisation for Rare Disorder & Rare Diseases International

Durhane Wong-Rieger | President, Chief Executive Officer | Canadian Organisation for Rare Disorder & Rare Diseases International » speaking at Orphan Drug Congress

Rachel Yang, Senior Advisor, Zhongshan Hospital Fudan University

Rachel Yang | Senior Advisor | Zhongshan Hospital Fudan University » speaking at Orphan Drug Congress

Mila Zaballos, Senior Manager, Clinical Operations, Allucent

Mila Zaballos | Senior Manager, Clinical Operations | Allucent » speaking at Orphan Drug Congress

Clara Zacharko, Senior Associate, CRA, Charles River Associates

Clara Zacharko | Senior Associate | CRA, Charles River Associates » speaking at Orphan Drug Congress

Elisabetta Zanon, Director, European Policy and Advocacy, Alliance for Regenerative Medicine

Elisabetta Zanon | Director, European Policy and Advocacy | Alliance for Regenerative Medicine » speaking at Orphan Drug Congress

Aldona Zygmunt, Public Affairs Director, Pfizer

Aldona Zygmunt | Public Affairs Director | Pfizer » speaking at Orphan Drug Congress

Get involved at World Orphan Drug Congress Europe 2025

 

 

TO SPONSOR


Kieran Duffin

Kieran.Duffin@terrapinn.com

 

Adam Mayar
Adam.Mayar@terrapinn.com

 

TO SPEAK


Abdu Kauroo
Abdu.Kauroo@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.